Nano-biotechnology provides highly efficient and versatile strategies to improve the diagnostic precision and therapeutic efficiency of serious diseases. The development of new biomaterial systems provides great opportunities for the successful clinical translation of nano-biotechnology for personalized biomedicine to benefit patients. As a new inorganic material system, mesoporous carbon biomaterials ( 
INTRODUCTION
Carbon-based materials are an emerging focus in the material science community and have received great attention for their high performance in extensive applications due to their unique structure and distinctive physiochemical properties and biological behaviors such as high chemical inertness/mechanical stability, excellent electrical conductivity, and satisfactory biocompatibility [1] [2] [3] . Of the carbon-family members, sp 2 carbon-based materials such as fullerene [4, 5] , carbon nanotubes [1, [6] [7] [8] [9] [10] [11] , carbon dots [12] [13] [14] , and graphene [15] [16] [17] [18] , have been explored for promising applications in biomedicine, including drug delivery, gene transfection, photothermal therapy, photodynamic therapy, biosensing, and even tissue engineering [19] [20] [21] . For instance, the hollow space in fullerene/carbon nanotubes and large surface-to-volume ratio of graphene can be used for the encapsulation and intracellular delivery of therapeutic agents. Moreover, carbon nanotubes and graphene show enhanced laser absorption in the near-infrared (NIR) region and high photothermal-conversion efficiency and can act as photothermal agents for photothermal cancer therapy. Pre-clinical evaluations of biodistribution, excretion, histocompatibility, hemocompatibility, and other properties are very encouraging: sp 2 carbon-based biomaterials are nontoxic and biocompatible at adequate doses, showing high clinical-translation potential [20, 22, 23] .
Biocompatible inorganic mesoporous materials have attracted great attention in biomedicine over the past decades [24] [25] [26] [27] [28] . The well-defined mesoporous structures with large surface area, high pore volume, and tunable pore sizes provide large reservoirs for guest molecules and show sustained drug-release profiles [29] [30] [31] . Mesoporous silica nanoparticles (MSNs) are one of the most representative and explored mesoporous biomaterials in biomedicine due to their high biocompatibility, tunable biodegradation, sustained drug-releasing performance, and easy surface modifications ( Fig. 1 ) [32] [33] [34] [35] . Compared with traditional MSNs and other carbon-based nanosystems (e.g., carbon nanotubes, graphene, carbon nanodots, and fullerene), mesoporous carbon biomaterials (MCBs), especially mesoporous carbon nanoparticles (MCNs), have been rarely used for biomedical applications, probably due to the lack of adequate synthetic methodologies to fabricate MCNs with desirable composition, dimension, structure, dispersity, and physiochemical properties for biomedicine. Typically, MCBs fabricated by conventional nanocasting methods possess irregular morphology and large particulate size, usually in the range of several micrometers. Furthermore, such MCBs are inherently hydrophobic, which severely restricts their potential applications in biomedicine where hydrophilic nanoparticles are highly desirable for intravenous injection and blood-vessel circulation. Compared with one-dimensional (1D) carbon nanotubes and two-dimensional (2D) graphene, quasi-zero-dimensional (0D) MCNs with spherical morphology facilitate the free
SYNTHETIC APPROACHES FOR MESOPOROUS CARBON MICRO/NANOPARTICLES
The broad applications of MCBs motivate the fast development of diverse chemical synthesis strategies such as soft-/ hard-templating approaches and in situ framework transformation to prepare MCBs with desirable compositional/ structural features. To fabricate desirable MCBs for specific biomedical applications, a rational choice of adequate synthetic strategy is crucial.
Nanocasting
The earliest and one of the most frequently adopted strategies to fabricate mesoporous carbon materials was based on the nanocasting process, generally using as-synthesized mesoporous silica as the host template [36] . Typically, mesoporous silica is synthesized as a hard template, followed by the impregnation and infiltration of organic carbon sources. Polymerization/carbonization of carbon sources at high temperature and removal of the silica template by chemical etching then produces ordered mesoporous carbon [37] . Based on the nanocasting method, Kim et al. [38] constructed spherical MCNs with ordered mesoporous structures using MCM-48 MSNs as the hard template. The average particle size of as-synthesized MCNs was ~150 nm. However, the traditional nanocasting method encounters severe problems in the fabrication of hydrophilic MCNs with uniform spherical morphology and high dispersity. Excess deposition of the carbon precursor on the outside of the silica templates is difficult to remove during the casting process, and a washing step would also remove the organic carbon precursor within the mesopores. Moreover, [39] . MCM-48 MSNs were initially functionalized with amino groups to generate positively charged -NH 3 + ions on the mesopore surface. Negatively charged carbonaceous polysaccharide (PS) from glucose aqueous solution under hydrothermal conditions was attracted to the mesopore surface via electrostatic interaction between PS molecules and the pre-established -NH 3 + ions. This amino-functionalization step avoided heterogeneous formation of carbon spheres on the outside of the MCM-48 template. The obtained MCNs could be well dispersed into aqueous solution with a hydrodynamic size of ~240 nm. A general confined co-assembly strategy was recently established to fabricate highly uniform mesoporous carbon microspheres employing three-dimensional (3D) ordered macroporous silica as the hard template [40] . These mesoporous carbon spheres range in size from 0.8 to 1 μm; however, the large particle sizes limit their utilization in intravenous drug delivery and diagnostic imaging.
Soft-templating
MCNs synthesized by the nanocasting method inversely duplicate the structure of hard templates; thus, their microstructure and morphology are limited to those of the initial templates. Additionally, aggregation of MCNs is intrinsically difficult to avoid in the traditional nanocasting process.
Recent advances in synthetic chemistry allowed synthesis of mesoporous carbon materials with ordered mesoporosity using a soft-templating method, i.e., organic-organic co-assembly strategy. For instance, amphiphilic triblock copolymers could serve as the soft template to self-assemble with resorcinol-formaldehyde resin to fabricate ordered mesoporous carbon materials [41, 42] . However, controlling the morphology and particle-size distribution of mesoporous carbon is difficult in traditional soft-templating synthesis. To solve this critical issue, Fang et al. [43] recently developed a low-concentration hydrothermal process to synthesize MCNs with ordered body-centered mesoporosity, spherical morphology, and narrow size distribution. Hydrogen bonding between Pluronic F127 (EO-106 PO 70 EO 106 ; EO: ethylene oxide, PO: propylene oxide) and resols promoted the formation of spherical phenolic resol-F127 monomicelles (Fig. 2a) . The low concentration of reactants was necessary to avoid excessive cross-linking among as-formed monomicelles. After hydrothermal treatment, the monomicelles assembled to generate the mesostructure by cross-linking with phenolic resols. MCNs were finally produced by further high-temperature calcination under N 2 protection. The achieved MCNs feature highly ordered mesoporosity and uniform spherical morphology (Figs 2b and c) . Importantly, the particle sizes of MCNs can be precisely tuned from 20 to 140 nm by changing the initial reagent concentrations. However, the low precursor concentration in this method is a strong limiting factor for the large-scale synthesis of MCNs and is thus unfavorable for industrial translations. 
REVIEWS

SCIENCE CHINA Materials
For the large-scale synthesis of MCNs with uniform spherical morphology and high dispersity, Liu et al. [44] reported the synthesis of ordered mesoporous resorcinol formaldehyde nanospheres by employing the cationic fluorocarbon surfactant FC4 (C 3 ) and triblock copolymer Pluronic F127 as the soft templates. Resorcinol and formaldehyde (RF) were used as organic carbon precursors to assemble with soft templates via hydrogen bonding (Fig. 3) . After further carbonization of as-synthesized polymer spheres, 80-400 nm MCNs were successfully synthesized. For MCNs with large pores, Tang et al. [45] synthesized nitrogen-doped MCNs with concurrent large (16 nm) mesopores and small (200 nm) particle sizes by self-polymerization of dopamine and co-assembly with a high-molecular-weight diblock polymer PB-b-PEO. The soft-templating strategy features controllable MCN morphology. For instance, well-controlled MCN shapes from sphere to rod were obtained by using low-molecular-weight phenolic resol as the carbon source and triblock copolymer Pluronic F127 as the structure-directing agent, with the concentration of F127 determining the resultant MCN morphology [46] . Thus, the particle size, pore size, and morphology of MCNs can be easily controlled by selecting adequate synthetic parameters for the soft-templating approach.
The soft-templating approach can also produce mesoporous carbon with concurrent uniform spherical morphology and extra-large particle sizes. We recently presented a novel emulsion-EISA (evaporation-induced self-assembly) strategy to fabricate uniform spherical mesoporous carbon with the sizes in the millimeter range for in vitro blood purification by hemoperfusion [47] . Triblock copolymer Pluronic F127 and phenolic resols were dissolved in ethanol, and the solution was dispersed in oil to form emulsion droplets (Fig. 4a) . The co-assembly of Pluronic F127 and phenolic resols tended to form mesophase hybrids upon the evaporation of ethanol. The asformed primary droplets fused with surrounding droplets to form very large polymer particles during thermal polymerization. After carbonization of the polymer particles, extra-large mesoporous carbon spheres (1.08-1.90 mm) were formed (Fig. 4b) . The mesopores of these carbon particles are disordered and worm-like (Fig. 4c) , and SEM images (Figs 4d and e) showed that these millimeter-sized mesoporous carbon particles had smooth surfaces. This research provides direct evidence that the soft-templating approach can synthesize spherical mesoporous carbon particles with a wide range of sizes.
In situ framework transformation
Traditional nanocasting using hard templates is time consuming and tedious because of the multi-step infiltration and post treatments. Particle aggregation and hydrophobicity are the two critical issues to be solved. Toward addressing these concerns, we recently developed a new in situ framework transformation strategy to synthesize hollow MCNs (HMCNs) with large hollow interiors and unique red blood cell (RBC) morphology [48] . Mesoporous organosilica nanoparticles (MONs) were initially synthesized with benzene-bridged organic-inorganic hybrid frameworks [49] . High-temperature calcination of mesoporous organosilica carbonizes the organic-benzene groups to form a mesoporous carbon framework within the silica framework. Upon removing the silica component by chemical etching, uniform HMCNs with RBC morphology were obtained (Figs 5a and b). Because the as-formed carbonaceous framework is not rigid enough to maintain the spherical and hollow nanostructure after removal of the silica component, most of the mesoporous carbon shell Figure 3 Schematic illustration of the fabrication of mesoporous polymer and MCNs. Reprinted with permission from Ref. [44] . Copyright 2013, Nature Publishing Group.
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MCNs, HMCNs, and rattle-type MCNs were recently synthesized using a "silica-assisted" synthetic strategy [50] . The polymerization of phenolic resols and hydroxylation/ condensation of tetraethylorthosilicate (TEOS) could form the organic-inorganic hybrid framework of composite nanoparticles. After further carbonization and removal of the silica component, highly dispersed MCNs with either solid or hollow nanostructures were obtained. Interestingly, the hollow nanostructure of MCNs was tuned by changing the initial precursor ratios of phenolic resols and TEOS [50] . Compared with the traditional nanocasting method, the in situ framework-transformation strategy is easy and scalable and is considered as a non-conventional method to fabricate MCNs with desirable key parameters.
Surface modification
The carbonaceous framework of MCNs is generally formed by calcination or hydrothermal treatment at elevated temperatures. Therefore, pristine MCNs are almost hydrophobic, which is unfavorable for broad biomedical application. Oxidization MCNs using a concentrated strong acid (e.g., HNO 3 and H 2 SO 4 ) is the most adopted strategy to improve their hydrophilicity [51] . This acid treatment can also modify the surface of MCNs with abundant functional groups (e.g., carboxyl groups) for further organic modifications such as PEGylation, targeting, stimuli-responsive grafting, diagnostic-imaging multifunctionalization, etc.
Hyaluronic acid (HA) was grafted onto the surface of MCNs to improve their colloidal stability/biocompatibili- 
BIOMEDICAL APPLICATIONS OF MCBS
The unique mesoporous nanostructure and carbonaceous composition of MCBs endow them with high biomedical performance. Similar to MSNs, the well-defined mesopores can provide reservoirs for guest drug molecules, and the carbonaceous framework and NIR-absorption property of MCBs can be used for photothermal conversion and therapy. The high absorption capability of MCBs shows the potential for application in bio-adsorption of toxic pathogenic substances and separation of peptides. The unique structural/compositional and physiochemical property of MCBs can be used to construct biosensing platforms.
MCBs for controlled delivery and release of therapeutic agents
MCNs are suitable for drug delivery because they allow hydrophobic interactions and supramolecular π-π stacking between the drug molecules and carbonaceous framework. Importantly, such non-covalent interactions are very sensitive to external triggers, which can be used to construct intelligent nanosystems with on-demand drug release. In addition, the well-defined mesopores serve as the storage reservoirs and diffusion path for guest molecules. The nanosized mesopores in MCNs can also reduce the drug-release rate, exhibiting sustained releasing behavior. Importantly, the tunable particle size and spherical morphology endow MCNs with intravenous transport capability. Therefore, MCNs can be regarded as one of the most promising carriers for efficient drug delivery. Kim et al. [38] synthesized CMK-1 MCNs via nanocasting using MCM-48 MSNs as the hard template. Fura-2 membrane-impermeable fluorescent dye molecules were encapsulated within MCNs for transmembrane delivery in human cancer cells (Fig. 6a) . The small particle size allowed MCNs to enter cells via a general endocytosis path, which was similar to most reported nanosystems. Differential interference contrast (DIC) microscopic images along the Z-axis of HeLa cells after co-incubation with MCNs (24 h) showed that MCNs were successfully internalized into the cells (Figs 6b-d) . Fura-2-loaded MCNs exhibited a sustained intracellular Fura-2 release profile. These results indicate that MCNs could act as transmembrane vectors for the delivery of loaded cargoes. However, the fabricated MCNs aggregate in aqueous solution due to their hydrophobicity after carbonization of furfuryl alcohol at elevated temperature. Compared to traditional MSNs, MCNs are much more suitable for the encapsulation and delivery of hydrophobic therapeutic agents because the carbonaceous SCIENCE CHINA Materials REVIEWS framework of MCNs can form specific π-π supramolecular interactions with aromatic drug molecules. We recently demonstrated that the as-synthesized MCNs showed loading capacity as high as 17% for the hydrophobic anticancer drug camptothecin (CPT) [39] , substantially higher than those of MSN-based nanocarriers [55] . Mesoporous carbon also exhibits a sustained release profile for an analgesic drug (antipyrine) [56] . The carbonaceous framework of HMCNs can form supramolecular π-π stacking interactions with aromatic drug molecules [17, 48] . We recently demonstrated that the anticancer drug doxorubicin (DOX) could be firmly anchored within mesopore channels of HMCNs by such π-π stacking interactions (Fig. 7a) , which could be disrupted by pH changes (Fig. 7b) or focused ultrasound irradiation (Fig. 7c ) [48] . For instance, the DOX-releasing amount was as low as 3.65% over 24 h in pH 7.4 buffer solution but increased to 12.51% and 37.61% in pH 6.0 and 4.6 solutions, respectively (Fig. 7b) . Because the microenvironment of tumor tissue is more acidic than normal tissue [15, [57] [58] [59] [60] , this pH-responsive DOX-releasing profile facilitates tumor-localized drug release from HMCNs. Focused ultrasound could also break the π-π stacking to trigger the DOX release. Furthermore, DOX release exhibited a pulsatile profile with pulses of high-intensity focused ultrasound (HIFU) irradiation (Fig. 7c) . This on-demand drug-release pattern is of practical importance because the focused ultrasound noninvasively penetrates to deep tumors [61] [62] [63] . As expected, HMCN-mediated DOX delivery significantly enhanced the therapeutic efficiency and sustainably inhibited tumor growth compared to free DOX (Fig. 7d) . Similar pHdependent DOX release from 90-nm MCNs was also demonstrated at pH 5.5, 7.4, and 9.0 [51] .
MCNs based core/shell composites show promise for desirable drug-loading/releasing patterns. Thus, MCNs were coated with a layer of mesoporous silica (designated 
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as mesoporous carbon@mesoporous silica, MC@MS) for the co-delivery of hydrophilic (cisplatin) and hydrophobic (paclitaxel, Ptxl) anticancer agents [64] . A unique hollow cavity was created between the mesoporous carbon core and mesoporous silica shell (Figs 8a and b) via thermal treatment. The hydrophobic MCNs show high affinity for water-insoluble anticancer agents, while the hydrophilic mesoporous silica shell attracts water-soluble agents (Fig.  8c) . The co-delivery of dual anticancer agents achieved synergistic therapeutic outcomes, efficiently killing both the normal ovarian cancer cells (SKOV3, Fig. 8d ) and drug-resistant A2780 cancer cells (Fig. 8e) .
To further control DOX release, HA was included as a gatekeeper to seal DOX within the mesopores of MCNs with a redox-responsive disulfide bond [52] . Upon the addition of enzyme Hyal-1, HA was degraded into low-molecular-weight fragments, triggering DOX release. Reducing agents such as GSH or DTT can break the disulfide bonds to remove the HA gatekeeper, substantially accelerating DOX release. Additionally, mesoporous carbon was employed as a carrier to enhance the inhibitory effect of celecoxib on the metastasis of MDA-MB-231 cells as demonstrated by wound healing, migration, and invasion analyses [65] . We recently demonstrated that HMCNs themselves significantly inhibit cancer cell metastasis by silencing the expressions of metastasis-promoting proteins such as matrix metalloproteinase MMP9, cyclo-oxygenase-2 (COX-2), and urokinase-type plasminogen activator (uPA) proteins [48] . Moreover, MCNs with large mesopores are effective adjuvants for efficient in vivo oral vaccine delivery [66] . To encapsulate biomacromolecules, magnetic mesoporous carbon spheres with dual mesopore structure were synthesized for the loading and sustained release of an antibacterial enzyme [67] . 
REVIEWS
MCBs for photothermal and synergistic therapy
Similar to carbon nanotubes and graphene [68] [69] [70] [71] [72] , MCNs show strong optical absorption in the NIR region (e.g., 808 nm), indicating potential utility as the photothermal agent for photothermal ablation of cancer cells because NIR light penetrates deeply into tissues and is harmless to normal tissues [52, 53] . Xu et al. [53] recently demonstrated that FA-targeted MCNs showed superior photothermal-conversion efficiency compared to graphene oxide and showed that NIR irradiation accelerated the release of pre-loaded anticancer drugs from MCNs. In addition, HA-targeted MCNs (MCNs-HA) were designed for targeted photothermal ablation of tumor and synergistic on-demand drug release [52] . MCNs-HA targeted to CD44 overexpressed cell membranes and entered the cancer cells, and then DOX release was triggered and accelerated by NIR irradiation. Thus, NIR irradiation played two roles: it was the source for photothermal conversion to ablate the cancer cells and the trigger for DOX release from MCNs. NIR-based photothermal therapy and DOX-based chemotherapy substantially enhanced the therapeutic efficiency, as demonstrated by the in vitro CCK-8 assay [52] . The combination of carbon and silica components could produce mesoporous composite materials with high photothermal conversion efficiency and controlled drug-releasing performance. Semi-graphitized carbon was introduced in situ to the mesopores of MSNs for concurrent photothermal therapy and drug delivery [73] . Wang et al. [74] designed an MCN core/mesoporous silica shell nanosystem. The hydrophilic mesoporous silica shell was used for surface modification to guarantee hydrophilicity and targeted drug delivery, and the hydrophobic graphitic mesoporous carbon core facilitated the encapsulation of hydrophobic drugs and NIR-induced photothermal therapy. DOX-loaded graphitic carbon@silica nanospheres exhibited pH-responsive drug-release profiles, and the introduction of NIR irradiation accelerated DOX release (Fig.  9a) . Treatment of SK-BR-3 with bafilomycin A1 to inhibit lysosome acidification and elevate the intralysosomal pH significantly inhibited the release of DOX from the carrier, as demonstrated by decreased DOX fluorescence within cancer cells (Figs 9b-e) . Therefore, intracellular DOX release was also pH-dependent. The synergistic therapeutic outcome of photothermal therapy and chemotherapy was further demonstrated in vitro.
NIR irradiation of the unique sp 2 and sp 3 carbonaceous structure of MCNs can produce additional cellular reactive oxygen species (ROS) and persistent free radicals, which further generates a large number of heat shock factor-1 protein homotrimers to suppress the activation and function of resistance-related proteins and genes (e.g., expression of MDR-1 and TP53 genes) in multidrug-resistant (MDR) cancer cells (Fig. 10) [75] . NIR-induced free radical generation by HMCNs was attributed to three factors. First, the electronic and chemical properties of HMCNs catalyze the oxidation of small molecules and produce ROS. Second, laser irradiation changes the features of HMCNs and the cancer cell microenvironment, which enhances electron transport within the cancer cells. Third, NIR irradiation destroys lysosomal membranes, releasing HMCNs into the cytoplasm and facilitating the catalysis of small molecules to generate more free radicals. Concurrent NIR-triggered free radical generation and DOX delivery can have synergistic therapeutic effects to combat MDR cancer cells.
MCBs for bio-imaging, bio-adsorption, and biosensing
Carbon dots and graphene quantum dots (QDs) have been extensively explored for cell labeling [76] [77] [78] [79] [80] [81] [82] . Using rational structural/compositional design, MCBs can be endowed with fluorescent properties for bio-imaging. Our Reprinted with permission from Ref. [74] . Copyright 2014, American Chemical Society.
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group recently synthesized fluorescent MCNs (F-MCNs) using a facile precursor carbonization-in-hot-solvent route [83] . Citric acid was decomposed and carbonized in 1-octadecane at 240°C to form ~100-nm F-MCNs with welldefined mesoporous structures and BET surface area of 864 m 2 g −1 , pore volume of 0.91 cm 3 g −1 , and average pore size of 2.7 nm. Notably, F-MCNs exhibited multicolor and upconversion photoluminescence (Figs 11a and b) , which was similar to reported characteristics of carbon dots with multicolor and wavelength-dependent fluorescence emissions upon laser excitation at different wavelengths. The F-MCNs showed photoluminescence efficiency up to 37%. Confocal laser scanning microscopic (CLSM) images showed that F-MCNs could illuminate cancer cells after endocytosis (Figs 11c-e) . The cell-labeling fluorescence was also photo-stable, potentially superior to organic fluorescein, which has relatively low photostability. The upconversion-photoluminescence cell labeling was demonstrated by green fluorescence emission after excitation at 637 nm (Fig. 11e) . Additionally, the well-defined mesoporosity of F-MCNs could act as a reservoir for the encapsulation and intracellular delivery of therapeutic agents, thereby serving as a theranostic agent.
For mesoporous carbon/silica composite nanoparticles, we recently integrated carbon components within the mesopores of mesoporous silica by directly carbonizing intra-mesopore P123 surfactant micelles (Fig. 12) [84] . We further created oxygen vacancies within the silica frame- 
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work by dehydrogenation between O 3 Si-H terminal groups at 600°C. Hybridization of C and Si nanocrystals within the framework could endow MSNs with unique characteristics for biomedical applications: the confined carbon component within the mesopores increases the loading capacity for a hydrophobic anticancer agent (camptothecin, CPT), and the confined Si nanocrystals within the framework present unique NIR-to-visible luminescence for cell labeling. Based on these characteristics, this composite nanocarrier is promising for the delivery of water-insoluble therapeutic agents and cancer theranostics. Furthermore, MCNs could be covalently grafted with fluorescein (e.g., 6-aminofluorescein) to study endocytosis by confocal fluorescent imaging [85] .
Mesoporous carbon possesses a high adsorption capacity for various guest molecules [86] [87] [88] [89] . In addition, their excellent biocompatibility and chemical/mechanical stability allow them to adsorb toxic pathogenic substances in vivo. We demonstrated that HMCNs could act as a clinical adsorbent for bilirubin [90] , which can cause crippling, athetoid cerebral palsy and even death if overproduced [91] . Various absorbents such as activated carbon, chitosan, resins, and porous TiO 2 have been employed as adsorption materials in hemoperfusion columns to remove bilirubin from the blood [90] . HMCNs with large hollow interiors and well-defined mesoporous shells (Figs 13a and b) were elaborately synthesized using silica core/ mesoporous silica shell core/shell-type templates and exhibited substantially higher bilirubin-adsorption capacity (304 mg g −1 ) compared with commercial activated carbon (70 mg g −1 ) and CMK-3 mesoporous carbon (198 mg g −1 ). This high bilirubin-adsorption capacity (Figs 13c and d) was attributed to the large hollow interior and well-defined mesopores of HMCNs, which left much more room for the bilirubin molecules. Moreover, HMCNs showed high bilirubin-adsorption selectivity and low hemolytic effect. Therefore, HMCNs show potential utility for clinic hemoperfusion.
During hemoperfusion, the blood cells should freely and safely pass through the adsorption column. Therefore, millimeter-sized carbon spheres are desirable because of the large cavities between the spheres. Accordingly, we employed millimeter-sized mesoporous carbon spheres (MMCSs) for clinical bilirubin adsorption [47] . The MMCSs exhibited smooth surfaces and well-defined mesopores in the matrix. No obvious hemolytic and blood-coagulation effects were found after the co-incubation of MMCSs with RBCs and blood plasma, indicating the high blood compatibility of MMCSs. Importantly, MMCSs possessed high adsorption capacity towards bilirubin (148.4 mg g 
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cycling capacity have potential use in bilirubin adsorption [92] .
A mesoporous carbon monolith with controlled porosity is desirable for various applications, e.g., as the filling material in hemoperfusion. Therefore, we recently synthesized a mesoporous carbon monolith with hierarchical porosity from macro-to meso/microporosities and a cylindrical morphology determined by the container used (Figs 14a and b) for bilirubin adsorption [93] . The framework of the mesoporous carbon monolith features ordered mesoporosity, which was replicated directly from the mesoporous silica monolith used as the hard template, and the monolith showed negligible hemolytic effect (Fig.  14c) . Importantly, the mesoporous carbon monolith had a high adsorption capacity for bilirubin (613 mg g . A similar strategy for bilirubin adsorption using nitrogen-doped, hierarchically porous carbon was developed using natural banana peel as the carbon precursor [94] .
MCBs can also be used in proteomics for disease diagnosis based on their high performance in peptide extraction 
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from biological samples for mass spectrometry (MS) analysis. The hydrophobicity of carbon and the size-selective mesopores provide ordered mesoporous carbon (OMC) with high extraction and recovery capabilities for serum peptides (Fig. 15 ) [95] . Using OMC extraction and 2D LC-MS/MS analysis, Qin et al. [95] identified 3402 different endogenous peptides from 20 μL human serum, a much higher number than obtained with MCM-41 mesoporous silica. CMK-3 OMCs yielded high enrichment of N-linked glycans from serum samples due to size-exclusion [96] . In addition, M-HMCNs were designed and synthesized for rapid capture of low-abundance peptides from biosamples based on their high hydrophobicity and rapid magnetic response [97] . These results demonstrate that MCBs could be used for high-throughput screening of peptide biomarkers for disease diagnosis and treatment.
Because of their well-defined mesoporous structure, large surface area, good conductivity, and chemical stability, MCBs can be used to construct biosensing platforms. Pt-containing mesoporous carbon enhances the electron transfer and redox capability of glucose oxidase. Based on this principle, You et al. [98] designed a glucose biosensor with a low detection limit. 3D-ordered graphitized mesoporous carbon with 6-nm pores facilitated the improvement of pore-size-dependent enzymatic stability, bioactivity, and the direct electron transfer of entrapped enzymes, which were designed to detect hydrogen peroxide [99] . NiFex-embedded OMC provided a high-performance electrochemical biosensing platform for amperometric detection of hydrogen peroxide or glucose with high selectivity, high stability, and low interference [100] . Mesoporous carbon was also mixed with an ionic liquid (1-butyl-3-methylimidazolium hexafluorophosphate) and protein (glucose oxidase) as the microelectrode and demonstrated enhanced electrocatalytic activity and sensitivity and excellent stability for glucose biosensing [101] .
Biocompatibility of MCBs
The biocompatibility of MSNs and several carbon-based biomaterials (e.g., carbon nanotubes and graphene) have been systematically investigated using several metrics, including biodistribution, excretion, biodegradation, histocompatibility, and hemocompatibility [102] [103] [104] [105] [106] [107] . They have been demonstrated to be non-toxic at desirable doses. MCBs combine the mesoporous structure/spherical morphology of MSNs with the carbonaceous composition of graphene. Thus, it is anticipated that MCBs might be biocompatible. We recently presented in vivo long-term (30-day) histocompatibility results showing no effect of oxidized HMCNs on the main organs of mice (heart, liver, spleen, lung, and kidney) after intravenous injection of 20 mg kg −1 HMCNs. No apparent pathological changes were observed using the hematoxylin-eosin staining protocol [48] . Because they lack surface Si-OH, MCBs did not induce the RBC hemolysis observed for traditional mesoporous silica, indicating high hemocompatibility [47, 90, 93, 94] . Although the preliminary biocompatibility results are encouraging, the biosafety evaluation of MCBs is still at the preliminary stage. The lack of general and adequate synthetic strategies to fabricate MCBs with highly desirable and reproducible structural/compositional parameters hinders the systematic evaluation of MCB biocompatibility. Biodegradation of MCBs is one of the most challenging future issues, similar to graphene and carbon nanotubes. Further rational structural design and compositional optimization of MCBs might provide strategies to solve this critical issue. Hence, the biocompatibility and biosafety of MCBs must be clarified as basic prerequisites for clinical translation.
CONCLUSIONS AND OUTLOOK
MCBs are considered the next generation of inorganic material systems for biomedical applications due to their com- 
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bination of mesoporous nanostructure and carbonaceous composition. This review summarizes recent progress in the rational design, chemical construction, and biomedical applications of MCBs. Synthetic strategies for MCBs, especially spherical MCNs, such as nanocasting, soft-templating, and in situ framework transformation are discussed in detail. Due to their unique mesoporous structure, carbonaceous composition, and high biocompatibility, MCBs show high performance in controlled drug delivery/release, photothermal therapy, synergistic therapy, fluorescent labeling, bio-adsorption of toxic pathogenic substances, peptide separation, and biosensing. However, the biomedical applications of MCBs are still at the very early stage. Additional work is required to promote clinical translation of MCBs, as detailed below.
Scalable synthetic strategies for MCBs with optimized structural and compositional parameters for biomedicine are needed. To date, no general, controllable, and standard methodologies for obtaining MCBs have been developed, especially for size-tunable and hydrophilic spherical MCNs, and such methods are essential for biomedical applications.
Surface modification of MCBs remains challenging. Traditional oxidization of MCNs can endow the carrier with some specific organic groups for further modification, but the strong oxidization process partially destroys the carbonaceous framework and the mesostructure of MCBs, leading to structural collapse and reduced photothermal-conversion efficiency. Most importantly, surface modification is necessary to endow drug carriers with targeted drug delivery and sustained/controlled drug release functions, which, though extensively applied on MSNs, have been seldom used with MCBs.
In addition to drug delivery, traditional mesoporous silica-based biomaterials have been extensively applied for gene delivery, photodynamic therapy, antibacterial treatments, and even tissue engineering. Comparatively, MCBs have been explored in limited biomedical fields. MCBs are anticipated to show high performance in further biomedical areas due to their unique structure, composition, and physiochemical properties. Furthermore, use of MCNs in diagnostic imaging is rare compared to MSNs and graphene. MCNs with integrated functional modules are expected to provide diagnostic imaging functions for magnetic resonance imaging, ultrasonography, computed tomography, positron emission computed tomography, etc.
Systematic biosafety evaluations of MCBs are necessary to guarantee their clinical translation in the near future, and these evaluations will strongly depend on development of methods to obtain desirable MCBs. The biosafety evaluations should focus on the biodistribution, biodegradation, excretion, and other specific toxicities such as neurotoxicity, reproductive toxicity, and embryonic toxicity. Quantitative analysis of MCBs in vivo might be challenging because their carbonaceous composition will be influenced by carbon in living systems. Radiolabelling of MCBs might solve this issue for future biosafety evaluation.
In conclusion, we have reviewed the interdisciplinary research regarding the biomedical applications of MCBs, including chemistry, material science, biomedicine, and nano-biotechnology viewpoints. The preliminary results for MCBs and their promising performances in biomedicine are a bright prospect for the carbon-based biomaterial family, though their development is much slower than for carbon nanotubes, graphene, carbon dots, and fullerene. The structural features and high biomedical performances of MCBs demonstrate that optimization of chemical compositions beyond silica will endow mesoporous materials with unique characteristics unavailable to common mesoporous silica. However, many more pre-clinical evaluations are needed to promote the clinical translation of MCBs to benefit human health, and these will benefit from closer collaboration among researchers from different areas.
